Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatase and actin regulator 2 (PHACTR2) is a human protein functioning primarily as a modulator of protein phosphatase activity and actin cytoskeleton organization. It is predicted to enable actin binding and protein phosphatase inhibitor activity, influencing cell shape, migration, and cytoskeletal dynamics. PHACTR2 is implicated in several pathways relevant to cell signaling and structure, and is associated with neurological diseases such as Parkinson’s disease, multiple sclerosis, and has been cited as a biomarker for Alzheimer’s disease. Diseases directly associated with mutations in the gene include body dysmorphic disorder and lissencephaly 8. PHACTR2 is ubiquitously expressed, and no drugs are known to target or interact with this protein; it is not a therapeutic receptor, enzyme, transporter, or transcription factor[3][4][10][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatase and actin regulator 2 (PHACTR2).